Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

272
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
272
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

1.6K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.6K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

181
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
181
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

2.5K
Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
2.5K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

3.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.4K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.

The New England journal of medicine·2026
Same author

Fifteen-minute consultation: A family-centred approach to recognising and managing differences in sex development.

Archives of disease in childhood. Education and practice edition·2026
Same author

The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis.

PloS one·2026
Same author

Adolescents' experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth.

Orphanet journal of rare diseases·2026
Same author

An Unusual Presentation of Severe Hypothyroidism in a Child With Undiagnosed Systemic Lupus Erythematous.

JCEM case reports·2026
Same author

The differential impact of automated insulin delivery systems on body mass index in children with type 1 diabetes.

Journal of pediatric endocrinology & metabolism : JPEM·2025

Related Experiment Video

Updated: Jul 9, 2025

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

9.7K

Hypoglycaemia in adrenal insufficiency.

Shien Chen Lee1, Elizabeth S Baranowski2, Rajesh Sakremath1

  • 1Department of Paediatrics, Princess Royal Hospital, Telford, United Kingdom.

Frontiers in Endocrinology
|December 6, 2023
PubMed
Summary

Adrenal insufficiency causes inadequate steroid production, leading to hypoglycemia, especially in neonates. Early recognition and management strategies are crucial for preventing severe outcomes.

Keywords:
adrenal insufficiencycortisolglucocorticoidhypoadrenalismhypoglycaemia

More Related Videos

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

23.5K
Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

8.1K

Related Experiment Videos

Last Updated: Jul 9, 2025

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

9.7K
A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

23.5K
Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

8.1K

Area of Science:

  • Endocrinology
  • Pediatric Endocrinology
  • Metabolic Disorders

Background:

  • Adrenal insufficiency (AI) results from insufficient steroid production (glucocorticoids, mineralocorticoids, androgens) by the adrenal glands.
  • AI can be primary (adrenal), secondary (pituitary ACTH), or tertiary (hypothalamic CRH), with congenital and acquired causes.
  • Congenital Adrenal Hyperplasia (CAH) due to 21-hydroxylase deficiency is a common inherited cause, affecting 1 in 10,000–15,000 newborns.

Purpose of the Study:

  • To review the pathogenesis of hypoglycemia in adrenal insufficiency.
  • To explore age-specific clinical features and disease burden of hypoglycemia in AI.
  • To summarize strategies for improved recognition and prevention of hypoglycemia in AI.

Main Methods:

  • Literature review focusing on pathogenesis, clinical features, and management of hypoglycemia in adrenal insufficiency.
  • Analysis of age-specific manifestations and disease burden.
  • Synthesis of evidence-based strategies for hypoglycemia prevention and management.

Main Results:

  • Hypoglycemia is a critical clinical feature of AI, linked to cortisol's role in glucose homeostasis and counter-regulatory mechanisms.
  • Neonates are particularly vulnerable, but older children and adults with AI also remain at risk.
  • Various etiologies of AI present with distinct hypoglycemic events and disease burdens.

Conclusions:

  • Hypoglycemia is a significant complication of adrenal insufficiency requiring careful monitoring and management.
  • Early recognition of hypoglycemia symptoms across all age groups is vital to prevent severe outcomes.
  • Strategies like continuous glucose monitoring and adjusted glucocorticoid replacement can improve hypoglycemia management in AI.